{
 "dataset": "tirzepatidetabletreview.com GLP-1 telehealth pricing database",
 "version": "v2026.08.14-5",
 "license": "CC BY 4.0 with attribution to tirzepatidetabletreview.com",
 "updated": "2026-08-14",
 "verification_statuses": {
  "independently_verified": "TTR completed the provider's checkout path and archived screenshots",
  "operator_supplied": "Figures supplied directly by the provider; independent verification queued",
  "third_party_reported": "Figures from dated third-party published checks; source_url cites them",
  "pending": "In the verification queue; no price published yet"
 },
 "normalization": {
  "advertised_price_usd": "Headline monthly price on the provider's site",
  "true_monthly_usd": "advertised + required membership + amortized one-time fees + shipping, at starting dose",
  "maintenance_monthly_usd": "true monthly cost at typical maintenance dose (tirzepatide 10-15 mg/wk)",
  "twelve_month_total_usd": "12 x true monthly on the cheapest recurring structure + one-time fees"
 },
 "disclosure": "NexLife is a commercial partner of this site; its records are operator_supplied until independently verified. See /disclosures/#ownership.",
 "programs": [
  {
   "provider": "NexLife",
   "program": "Tirzepatide standard injectable",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 169,
   "commitment_pricing_usd": {
    "monthly": 169,
    "3mo": 159,
    "6mo": 149,
    "12mo": 139
   },
   "membership_fee_usd": 0,
   "consultation_fee_usd": 0,
   "shipping_usd": 0,
   "dose_based_increases": false,
   "true_monthly_usd": 169,
   "maintenance_monthly_usd": 169,
   "twelve_month_total_usd": 1668,
   "commitment_required": "none (12-mo optional for lowest rate)",
   "cancellation": "Site FAQ: cancel any time via dashboard. Operator briefing said 30 days' notice. Conflict recorded.",
   "pharmacy": "Partner list published on site: Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy, 'or other qualified 503A/503B' (varies by state; USP <797> cited)",
   "pharmacy_type": null,
   "states_served": "50-state claim published on site ('Licensed nationwide') - license-level verification pending",
   "status": "operator_supplied",
   "verified": "2026-08-14",
   "source_url": "https://nexlife.us/pages/tirzepatide-all-plans",
   "notes": "Live selector confirms $169/159/149/139 exactly. Confirmed against live nexlife.us page (fetched 2026-08-14): plan-selector prices match. Page also publishes: pharmacy partner list (Absolute, Hallandale, Red Rock, Empower, Strive, 'or other qualified 503A/503B'), LegitScript certification seal, 50-state availability claim, money-back warranty (10% in 6 months, ToS apply), no-membership and flat-at-every-dose language, Klarna/Afterpay/Affirm + FSA/HSA. Recorded discrepancies: stale FAQ/OG blocks elsewhere on site still show an older price generation (tirz $186–215, sema $145–165); cancellation stated as 'any time via dashboard' on injection pages but 'written request + 30-day notice' on ODT pages; marketing cites 'up to 24.3%' tirzepatide loss vs the commonly cited SURMOUNT-1 20.9%; two conflicting Trustpilot displays (4.7 widget vs 4.1/2,344).",
   "website": "https://nexlife.us/",
   "live_page_check": "2026-08-14 fetch of nexlife.us/pages/tirzepatide-all-plans: plan selector displays $169/159/149/139 - matches operator briefing. CONFLICT: the site's own sitewide pricing FAQ (captured same day on the microdose page) prices standard tirzepatide at $215/195/190/186, and the plans page's OG metadata says 'from $186/month'. Unresolved on-site conflict; selector price shown as advertised, conflict logged publicly.",
   "credentials_claimed": "LegitScript-certified (seal #46376918, verifiable); partner pharmacies claimed LegitScript/NABP/NCPA; per-batch third-party testing (potency, sterility, pH, endotoxin)",
   "marketing_flags": "Efficacy marketed 'up to 24.3%' attributed to SURMOUNT-1 (commonly cited: 20.9% treatment-regimen); two conflicting Trustpilot widgets on one page (4.7 vs 4.1/2,344); outcomes stat attributed to n=518 and n=111 in different sections; warranty worded 'lose up to 10%' in one section, 'lose at least 10%' in FAQ - guarantee policy page governs",
   "payment": "FSA/HSA accepted; Klarna, Afterpay, Affirm financing"
  },
  {
   "provider": "NexLife",
   "program": "Semaglutide standard injectable",
   "medication": "semaglutide",
   "format": "injection",
   "advertised_price_usd": 139,
   "commitment_pricing_usd": {
    "monthly": 139,
    "3mo": 132,
    "6mo": 125,
    "12mo": 119
   },
   "membership_fee_usd": 0,
   "true_monthly_usd": 139,
   "maintenance_monthly_usd": 139,
   "twelve_month_total_usd": 1428,
   "dose_based_increases": false,
   "status": "operator_supplied",
   "verified": "2026-08-14",
   "source_url": "https://nexlife.us/pages/semaglutide-all-plans",
   "notes": "Live selector confirms $139/132/125/119 exactly (secondary on-site texts show $135 and stale $145 — conflicts recorded). Confirmed against live nexlife.us page (fetched 2026-08-14): plan-selector prices match. Page also publishes: pharmacy partner list (Absolute, Hallandale, Red Rock, Empower, Strive, 'or other qualified 503A/503B'), LegitScript certification seal, 50-state availability claim, money-back warranty (10% in 6 months, ToS apply), no-membership and flat-at-every-dose language, Klarna/Afterpay/Affirm + FSA/HSA. Recorded discrepancies: stale FAQ/OG blocks elsewhere on site still show an older price generation (tirz $186–215, sema $145–165); cancellation stated as 'any time via dashboard' on injection pages but 'written request + 30-day notice' on ODT pages; marketing cites 'up to 24.3%' tirzepatide loss vs the commonly cited SURMOUNT-1 20.9%; two conflicting Trustpilot displays (4.7 widget vs 4.1/2,344).",
   "website": "https://nexlife.us/",
   "live_page_check": "2026-08-14: semaglutide-all-plans fetch returned no content (attempted twice). CONFLICT: the site's pricing FAQ prices semaglutide at $165/149/147/145 vs operator briefing $139/132/125/119; the tirzepatide page's OG metadata says 'from $145'. Selector unconfirmed; conflict recorded, checkout walk pending."
  },
  {
   "provider": "NexLife",
   "program": "Tirzepatide microdose",
   "medication": "tirzepatide",
   "format": "injection (sub-therapeutic dose)",
   "advertised_price_usd": 189,
   "commitment_pricing_usd": {
    "monthly": 189,
    "3mo": 159,
    "6mo": 150,
    "12mo": 147
   },
   "true_monthly_usd": 189,
   "twelve_month_total_usd": 1764,
   "status": "operator_supplied",
   "verified": "2026-08-14",
   "source_url": "https://nexlife.us/pages/microdose-tirzepatide-program",
   "evidence_note": "Doses below SURMOUNT-studied 5-15 mg/wk range; no published outcome trials for permanent sub-therapeutic dosing",
   "website": "https://nexlife.us/",
   "notes": "Live selector confirms $169/159/149/139 exactly. Confirmed against live nexlife.us page (fetched 2026-08-14): plan-selector prices match. Page also publishes: pharmacy partner list (Absolute, Hallandale, Red Rock, Empower, Strive, 'or other qualified 503A/503B'), LegitScript certification seal, 50-state availability claim, money-back warranty (10% in 6 months, ToS apply), no-membership and flat-at-every-dose language, Klarna/Afterpay/Affirm + FSA/HSA. Recorded discrepancies: stale FAQ/OG blocks elsewhere on site still show an older price generation (tirz $186–215, sema $145–165); cancellation stated as 'any time via dashboard' on injection pages but 'written request + 30-day notice' on ODT pages; marketing cites 'up to 24.3%' tirzepatide loss vs the commonly cited SURMOUNT-1 20.9%; two conflicting Trustpilot displays (4.7 widget vs 4.1/2,344).",
   "live_page_check": "2026-08-14 fetch: selector displays $189/159/150/147 (12-mo total $1,764, 'Save $504'), agreeing with the sitewide FAQ. SUPERSEDES operator briefing of $159/149/139/129 - correction issued. Product imaging discloses 20 mg/mL in a 3 mL vial (60 mg). Microdose eligibility marketed at BMI >=23 (standard >=27). Some formulations may include methylcobalamin (B12) per site disclaimer."
  },
  {
   "provider": "NexLife",
   "program": "Semaglutide microdose",
   "medication": "semaglutide",
   "format": "injection (sub-therapeutic dose)",
   "advertised_price_usd": 129,
   "commitment_pricing_usd": {
    "monthly": 129,
    "3mo": 119,
    "6mo": 114,
    "12mo": 110
   },
   "true_monthly_usd": 129,
   "twelve_month_total_usd": 1320,
   "status": "operator_supplied",
   "verified": "2026-08-14",
   "source_url": "https://nexlife.us/pages/microdose-semaglutide-program",
   "notes": "Live selector confirms $139/132/125/119 exactly (secondary on-site texts show $135 and stale $145 — conflicts recorded). Confirmed against live nexlife.us page (fetched 2026-08-14): plan-selector prices match. Page also publishes: pharmacy partner list (Absolute, Hallandale, Red Rock, Empower, Strive, 'or other qualified 503A/503B'), LegitScript certification seal, 50-state availability claim, money-back warranty (10% in 6 months, ToS apply), no-membership and flat-at-every-dose language, Klarna/Afterpay/Affirm + FSA/HSA. Recorded discrepancies: stale FAQ/OG blocks elsewhere on site still show an older price generation (tirz $186–215, sema $145–165); cancellation stated as 'any time via dashboard' on injection pages but 'written request + 30-day notice' on ODT pages; marketing cites 'up to 24.3%' tirzepatide loss vs the commonly cited SURMOUNT-1 20.9%; two conflicting Trustpilot displays (4.7 widget vs 4.1/2,344).",
   "website": "https://nexlife.us/",
   "live_page_check": "2026-08-14: sitewide FAQ confirms $129/119/114/110 - briefing matched on three rungs; 3-mo rung corrected $117->$119."
  },
  {
   "provider": "NexLife",
   "program": "Tirzepatide sublingual ODT",
   "medication": "tirzepatide",
   "format": "sublingual ODT",
   "advertised_price_usd": 229,
   "commitment_pricing_usd": {
    "monthly": 229,
    "3mo": 219,
    "6mo": 205,
    "12mo": 199
   },
   "commitment_totals_usd": {
    "3mo": 657,
    "6mo": 1230,
    "12mo": 2388
   },
   "true_monthly_usd": 229,
   "twelve_month_total_usd": 2388,
   "status": "operator_supplied",
   "verified": "2026-08-14",
   "source_url": "https://nexlife.us/pages/sublingual-tirzepatide-odt",
   "evidence_note": "No FDA-approved oral tirzepatide exists; no published human PK/efficacy data for compounded sublingual tirzepatide as of 2026-08",
   "website": "https://nexlife.us/",
   "notes": "Live selector confirms $169/159/149/139 exactly. Confirmed against live nexlife.us page (fetched 2026-08-14): plan-selector prices match. Page also publishes: pharmacy partner list (Absolute, Hallandale, Red Rock, Empower, Strive, 'or other qualified 503A/503B'), LegitScript certification seal, 50-state availability claim, money-back warranty (10% in 6 months, ToS apply), no-membership and flat-at-every-dose language, Klarna/Afterpay/Affirm + FSA/HSA. Recorded discrepancies: stale FAQ/OG blocks elsewhere on site still show an older price generation (tirz $186–215, sema $145–165); cancellation stated as 'any time via dashboard' on injection pages but 'written request + 30-day notice' on ODT pages; marketing cites 'up to 24.3%' tirzepatide loss vs the commonly cited SURMOUNT-1 20.9%; two conflicting Trustpilot displays (4.7 widget vs 4.1/2,344).",
   "live_page_check": "2026-08-14: live-page fetch attempted, content not retrieved. Figures remain operator briefing only."
  },
  {
   "provider": "NexLife",
   "program": "Semaglutide sublingual ODT",
   "medication": "semaglutide",
   "format": "sublingual ODT",
   "advertised_price_usd": 199,
   "commitment_pricing_usd": {
    "monthly": 199,
    "3mo": 185,
    "6mo": 177,
    "12mo": 165
   },
   "commitment_totals_usd": {
    "3mo": 597,
    "6mo": 1062,
    "12mo": 1980
   },
   "true_monthly_usd": 199,
   "twelve_month_total_usd": 1980,
   "status": "operator_supplied",
   "verified": "2026-08-14",
   "source_url": "https://nexlife.us/pages/sublingual-semaglutide-odt",
   "evidence_note": "Oral peptide bioavailability ~1% even for approved Rybelsus with SNAC enhancer",
   "website": "https://nexlife.us/",
   "notes": "Live selector confirms $139/132/125/119 exactly (secondary on-site texts show $135 and stale $145 — conflicts recorded). Confirmed against live nexlife.us page (fetched 2026-08-14): plan-selector prices match. Page also publishes: pharmacy partner list (Absolute, Hallandale, Red Rock, Empower, Strive, 'or other qualified 503A/503B'), LegitScript certification seal, 50-state availability claim, money-back warranty (10% in 6 months, ToS apply), no-membership and flat-at-every-dose language, Klarna/Afterpay/Affirm + FSA/HSA. Recorded discrepancies: stale FAQ/OG blocks elsewhere on site still show an older price generation (tirz $186–215, sema $145–165); cancellation stated as 'any time via dashboard' on injection pages but 'written request + 30-day notice' on ODT pages; marketing cites 'up to 24.3%' tirzepatide loss vs the commonly cited SURMOUNT-1 20.9%; two conflicting Trustpilot displays (4.7 widget vs 4.1/2,344).",
   "live_page_check": "2026-08-14: live-page fetch attempted, content not retrieved. Figures remain operator briefing only."
  },
  {
   "provider": "Henry Meds",
   "program": "Tirzepatide bundle (oral/sublingual tablet formats)",
   "medication": "tirzepatide",
   "format": "oral/sublingual tablet",
   "advertised_price_usd": 179,
   "membership_fee_usd": 0,
   "true_monthly_usd": 179,
   "twelve_month_total_usd": 2148,
   "states_served": "~41 (reported)",
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://www.rxpepsdirect.com/learn/best-compounded-tirzepatide-telehealth",
   "evidence_note": "Headline covers tablet formats with limited published evidence; see injectable record",
   "website": "https://henrymeds.com/"
  },
  {
   "provider": "Henry Meds",
   "program": "Tirzepatide injectable",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 399,
   "true_monthly_usd": 449,
   "maintenance_monthly_usd": 549,
   "dose_based_increases": true,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://skinnyvip.com/blog/compounded-glp1-telehealth-pricing-comparison-2026/",
   "notes": "~$399 first month, ~$449 recurring, higher doses ~+$100/mo, per third-party check",
   "website": "https://henrymeds.com/"
  },
  {
   "provider": "Mochi Health",
   "program": "Tirzepatide (membership + medication)",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 199,
   "membership_fee_usd": 79,
   "true_monthly_usd": 278,
   "twelve_month_total_usd": 3336,
   "dose_based_increases": false,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://dosemate.com/resources/henry-meds-vs-mochi-health-weight-loss",
   "conflict_note": "Other 2026 reports describe $149 membership + medication from $249 (~$398 effective); TTR checkout verification queued to resolve",
   "website": "https://joinmochi.com/"
  },
  {
   "provider": "MEDVi",
   "program": "Tirzepatide injectable",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 199,
   "true_monthly_usd": 199,
   "maintenance_monthly_usd": null,
   "dose_based_increases": true,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "Reported lowest injectable entry price at 2.5-5 mg starting doses; maintenance-dose figure pending Re-confirmed 2026-08-14 at tirzepatide.us.com/cost (Apr 2026 page): $199 start at 2.5–5 mg, with that source noting 12.5–15 mg 'may add $30–80/month at most providers' — maintenance price remains the open question. Source flags itself affiliate-supported and lists MEDVi as its Editor's Choice (incentive noted).",
   "website": "https://medvi.com/"
  },
  {
   "provider": "Hims",
   "program": "Compounded tirzepatide",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 329,
   "true_monthly_usd": 329,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://trytrimi.com/blog/cheapest-tirzepatide-providers-ranked-2026",
   "notes": "Brand-forward platform; compounded availability has shifted repeatedly since 2025 Historical compounded figure only; post-March-2026 Novo partnership the brand-Wegovy lane is the live product.",
   "website": "https://hims.com/"
  },
  {
   "provider": "Ro",
   "program": "Tirzepatide cash tiers / brand pathway",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 199,
   "true_monthly_usd": 349,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "$199-349 by tier reported; strongest insurance pathway for branded Zepbound tirzepatide.us.com/cost (Apr 2026) reports $329 start for the cash tier — consistent with our $199–349 band; Ro's real product remains the insurance pathway.",
   "website": "https://ro.co/"
  },
  {
   "provider": "Eden",
   "program": "Compounded tirzepatide",
   "medication": "tirzepatide",
   "format": "injection",
   "advertised_price_usd": 249,
   "true_monthly_usd": 296,
   "states_served": "~50 (reported)",
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "Owns Contigo compounding pharmacy (acquired 2025), per third-party reporting $296 start re-confirmed 2026-08-14 at tirzepatide.us.com/cost.",
   "website": "https://tryeden.com/"
  },
  {
   "provider": "LillyDirect",
   "program": "Zepbound single-dose vials (FDA-approved brand)",
   "medication": "tirzepatide",
   "format": "injection (brand vials)",
   "advertised_price_usd": 349,
   "true_monthly_usd": 349,
   "maintenance_monthly_usd": 499,
   "twelve_month_total_usd": 4188,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "$349-499/mo by dose, self-pay; the only FDA-approved product in this dataset",
   "website": "https://lillydirect.lilly.com/"
  },
  {
   "provider": "Zepbound retail (reference)",
   "program": "Brand retail cash price",
   "medication": "tirzepatide",
   "format": "injection (pens)",
   "advertised_price_usd": 1086,
   "true_monthly_usd": 1086,
   "twelve_month_total_usd": 13032,
   "status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "Re-confirmed 2026-08-14: Zepbound retail ~$1,049 (Costco) to ~$1,099 (CVS); Mounjaro ~$1,089–1,135. Matches our $1,086–1,135 reference band."
  },
  {
   "provider": "Embody",
   "status": "pending",
   "notes": "Pricing changed at least twice in summer 2026: new-customer terms effective Jul 1 list tirzepatide $129 m-t-m / $119 12-mo prepay and semaglutide $79 / $69 (The RX Index, from Embody's Terms); glp1picks (verified Aug 2026) reports injectables went flat Jul 31 at $119 tirz / $69 sema with no commitment. Older retired 'Start' plan jumped $149→$299+ — the source of many complaints. CONFLICT: PlexusDx (a competing seller) reports a July checkout showing $349 tirz / $299 sema — recorded with incentive flag, not averaged. Trustpilot: 3.6 verified (3,869 reviews) vs 4.9 marketed. Operator Modern Metabolic Medicine, Inc. also runs SnagRx at identical prices; clinicians via OpenLoop Health; four pharmacy partners named in Terms per weightlossproviderguide. Oral 'gum' tirzepatide $329/mo (or +$50 over injectable) — no published human absorption data; our tablet-format caveat applies.",
   "medication": "compounded tirzepatide (injection; oral gum extra)",
   "advertised_price_monthly": 129,
   "true_monthly_low": 119,
   "true_monthly_high": 129,
   "membership_fee": 0,
   "commitment": "none (month-to-month at $129; $119 on 12-mo prepay)",
   "dose_based_increases": "no (flat claimed)",
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://therxindex.com/embody-glp1-reviews/",
   "website": "https://joinem.co"
  },
  {
   "provider": "AltRx",
   "status": "pending",
   "medication": "compounded GLP-1 (semaglutide/tirzepatide)",
   "advertised_price_monthly": 89,
   "true_monthly_low": 89,
   "true_monthly_high": 129,
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://www.exploretreatments.com/embody-glp1-weight-loss-review/",
   "notes": "Reported $89–129/mo depending on medication (exploretreatments, Jun 2026). Thin single-source figure; structure unverified."
  },
  {
   "provider": "Rift",
   "status": "pending"
  },
  {
   "provider": "Ivim Health",
   "status": "pending",
   "website": "https://www.ivimhealth.com",
   "medication": "compounded tirzepatide (+ brand/insurance concierge, Foundayo access)",
   "advertised_price_monthly": 133,
   "membership_fee": 74.99,
   "true_monthly_low": 208,
   "true_monthly_high": 258,
   "commitment": "prepay tiers (12-mo for $133 rate; $183 at 6-mo)",
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://health.usnews.com/best-diet/medication/ivim-health",
   "notes": "Textbook membership-math case: tirzepatide advertised from $133/mo (12-mo prepay; $183 at 6-mo) PLUS a required $74.99/mo membership (first month free per operator page) → true ~$208–258/mo. Semaglutide from $75/mo + membership. Weekly provider check-ins ('GLP-1 ID' individualized dosing), nationwide claim, HSA/FSA, insurance concierge for brand meds incl. Foundayo. Sources: U.S. News (Aug 2026) + ivimhealth.com pricing pages."
  },
  {
   "provider": "Brello Health",
   "status": "pending",
   "medication": "compounded tirzepatide",
   "advertised_price_monthly": 349,
   "true_monthly_low": 349,
   "true_monthly_high": 349,
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "Reported $349 start (tirzepatide.us.com, Apr 2026) — top of that source's compounded table. No further structure independently documented; membership, dosing curve, and pharmacy remain open."
  },
  {
   "provider": "Lavender Sky Health",
   "status": "pending"
  },
  {
   "provider": "Trillium",
   "status": "pending"
  },
  {
   "provider": "ShedRx",
   "status": "pending",
   "website": "https://shedrx.com/",
   "medication": "compounded tirzepatide (injection; drops/lozenges extra formats)",
   "advertised_price_monthly": 199,
   "true_monthly_low": 189,
   "true_monthly_high": 375,
   "dose_based_increases": "yes (multiple sources)",
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://www.glp1drugs.org/l/shedrx-review",
   "notes": "Sources conflict on the band — recorded, not averaged: glp1drugs.org lists $199 injections (drops $229, lozenges $199; brand Wegovy/Zepbound add a $99/mo fee); FormBlends reports $189–249 starter and a $195–375 patient-reported range with dose escalation (NB: FormBlends competes in the same market — incentive flag); PlexusDx (also a competitor) says $150–250. Asynchronous-only intake; dispensing pharmacy disclosed on the label, not up front. Daily drops/lozenges carry the same no-human-absorption-data caveat as every non-injectable tirzepatide."
  },
  {
   "provider": "Orderly",
   "status": "pending"
  },
  {
   "provider": "Found",
   "status": "pending",
   "website": "https://joinfound.com/",
   "medication": "GLP-1 program (details vary)",
   "advertised_price_monthly": 129,
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://www.glp1picks.com/reviews/embody",
   "notes": "Listed at $129/mo in glp1picks' verified Aug 2026 provider table; program structure and medication inclusion unverified in our pass."
  },
  {
   "provider": "Fifty 410",
   "status": "pending"
  },
  {
   "provider": "Trimi Health",
   "status": "pending",
   "notes": "$125/mo annual tirzepatide self-published claim; independent check queued"
  },
  {
   "provider": "Noom Med",
   "status": "pending",
   "website": "https://noom.com/",
   "medication": "GLP-1 program (details vary)",
   "advertised_price_monthly": 79,
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://www.glp1picks.com/reviews/embody",
   "notes": "Listed at $79/mo in glp1picks' verified Aug 2026 provider table — likely a program-fee-style entry price; medication inclusion and true monthly cost unverified. Treat as an entry-point figure only."
  },
  {
   "provider": "Calibrate",
   "status": "pending",
   "website": "https://joincalibrate.com/"
  },
  {
   "provider": "Form Health (Sequence)",
   "status": "pending",
   "website": "https://formhealth.co/"
  },
  {
   "provider": "Hers",
   "status": "pending",
   "website": "https://forhers.com/",
   "medication": "compounded tirzepatide",
   "advertised_price_monthly": 299,
   "true_monthly_low": 299,
   "true_monthly_high": 299,
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://tirzepatide.us.com/cost/",
   "notes": "Reported $299 start (tirzepatide.us.com, Apr 2026). House-wide caveat: sibling brand of Hims — same Novo partnership pivot dynamics apply; confirm current compounded availability at intake."
  },
  {
   "provider": "Aspire Health",
   "status": "pending"
  },
  {
   "provider": "Nava Health",
   "status": "pending"
  },
  {
   "provider": "Skinny Rx",
   "status": "pending"
  },
  {
   "provider": "LillyDirect",
   "medication": "Foundayo (orforglipron)",
   "format": "oral tablet (non-peptide)",
   "advertised_price_monthly": 149,
   "true_monthly_low": 149,
   "true_monthly_high": 349,
   "membership_fee": 0,
   "shipping": 0,
   "consultation": "prescription required",
   "annual_total_low": 1788,
   "annual_total_high": 4188,
   "commitment": "none",
   "dose_based_increases": true,
   "pharmacy": "LillyDirect fulfillment",
   "pharmacy_type": "manufacturer channel",
   "states_served": "US",
   "cancellation": "n/a",
   "verified": "2026-08-14",
   "verification_status": "third_party_reported",
   "source_url": "https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill",
   "website": "https://lillydirect.lilly.com/",
   "notes": "Approved Apr 1 2026; self-pay $149 (0.8mg) to $349 (14.5/17.2mg); $25/mo eligible commercial; $50/mo Medicare Bridge."
  },
  {
   "provider": "NovoCare",
   "medication": "Oral Wegovy 25 mg (semaglutide)",
   "format": "oral tablet (peptide + SNAC)",
   "advertised_price_monthly": 149,
   "true_monthly_low": 149,
   "true_monthly_high": 149,
   "membership_fee": 0,
   "shipping": 0,
   "consultation": "prescription required",
   "annual_total_low": 1788,
   "annual_total_high": 1788,
   "commitment": "none",
   "dose_based_increases": false,
   "pharmacy": "NovoCare fulfillment",
   "pharmacy_type": "manufacturer channel",
   "states_served": "US",
   "cancellation": "n/a",
   "verified": "2026-08-14",
   "verification_status": "third_party_reported",
   "source_url": "https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/",
   "website": "https://www.novocare.com/",
   "notes": "Launched Dec 2025; fasting rules apply (SNAC formulation)."
  },
  {
   "provider": "PlexusDx",
   "medication": "Compounded tirzepatide (injection)",
   "format": "injectable",
   "advertised_price_monthly": 289,
   "true_monthly_low": 289,
   "true_monthly_high": 289,
   "membership_fee": 0,
   "shipping": null,
   "consultation": null,
   "annual_total_low": 3468,
   "annual_total_high": 3468,
   "commitment": "none stated",
   "dose_based_increases": null,
   "pharmacy": "unverified",
   "pharmacy_type": "unverified",
   "states_served": "unverified",
   "cancellation": "unverified",
   "verified": "2026-08-14",
   "verification_status": "third_party_reported",
   "source_url": "https://plexusdx.com/blogs/learn/best-compounded-tirzepatide-providers-plexusdx",
   "website": "https://plexusdx.com/",
   "notes": "Diagnostics company selling its own program and ranking itself #1 in its comparison content — a self-ranking conflict we flag on /review-consensus/. Also lists an oral tirzepatide protocol at $349/mo ($279 on 6-month): unproven format, no human absorption data."
  },
  {
   "provider": "BMI Doctors",
   "medication": "Compounded tirzepatide (injection)",
   "format": "injectable",
   "advertised_price_monthly": 139,
   "true_monthly_low": 139,
   "true_monthly_high": null,
   "membership_fee": null,
   "shipping": null,
   "consultation": null,
   "annual_total_low": 1668,
   "annual_total_high": null,
   "commitment": "12-month plan for the $139 rate",
   "dose_based_increases": null,
   "pharmacy": "unverified",
   "pharmacy_type": "unverified",
   "states_served": "unverified",
   "cancellation": "unverified",
   "verified": "2026-08-14",
   "verification_status": "third_party_reported",
   "source_url": "https://policylab.us/tirzepatide/best-online-compounding-pharmacy/",
   "website": "https://www.bmidoctors.com/",
   "notes": "Third-party ranking reports a $139/mo 12-month plan; month-to-month price, fees, and pharmacy unverified. Matches NexLife's annual figure — the head-to-head verification question writes itself."
  },
  {
   "provider": "Remedy Meds",
   "medication": "compounded tirzepatide (+ brand access)",
   "advertised_price_monthly": 399,
   "true_monthly_low": 399,
   "true_monthly_high": 399,
   "membership_fee": 0,
   "commitment": "month-to-month",
   "dose_based_increases": "no (flat; no dose upcharges per U.S. News)",
   "verification_status": "third_party_reported",
   "verified": "2026-08-14",
   "source_url": "https://www.forbes.com/health/weight-loss/remedy-meds-review/",
   "notes": "Forbes Health (Apr 2026) and U.S. News (Aug 2026) agree: $399/mo tirzepatide, $299 semaglutide, flat pricing, no membership, no dose upcharges, medication+care+shipping bundled; 49 states via 503A partners; brand via program: Ozempic $1,299 / Zepbound $1,399. Conflicts recorded: bestmedshub (May) lists $199–349; PlexusDx July capture found only a $189 microdose tier published openly with standard pricing quiz-gated. Reputation split: Trustpilot 4.6 (9,600+) vs BBB C- with recurring-billing complaints. Premium positioning = unlimited clinician video/messaging."
  }
 ],
 "link_policy": "Outbound provider links carry utm_source=tirzepatidetabletreview.com, utm_medium=referral, utm_campaign=provider_ledger, utm_content=<page>, utm_term=<provider>. Partner links (NexLife) use rel=sponsored; all other provider links use rel=nofollow. Watchlist providers remain unlinked until their domains are verified."
}